Literature DB >> 20351670

CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study.

P Zamboni1, E Menegatti, B Weinstock-Guttman, C Schirda, J L Cox, A M Malagoni, D Hojnacki, C Kennedy, E Carl, M G Dwyer, N Bergsland, R Galeotti, S Hussein, I Bartolomei, F Salvi, M Ramanathan, R Zivadinov.   

Abstract

AIM: We previously reported unexpectedly robust associations between vascular haemodynamic (VH) anomalies in the principal extracranial cerebral veins, causing chronic cerebrospinal venous insufficiency (CCSVI), and multiple sclerosis (MS). Aim of this study was to investigate the relationship between the VH changes and MRI measures of MS disease severity in a cross sectional survey.
METHODS: The number of anomalous VH criteria were measured using an echo-color Doppler, whereas CSF flow, atrophy and lesion measures were obtained from quantitative magnetic resonance imaging (MRI) analysis in sixteen consecutive relapsing-remitting MS patients, (mean age: 36.1+/-SD 7.3 years, disease duration: 7.5+/-1.9 years and median EDSS: 2.5) and in 8 healthy controls (HC) with similar age and sex distributions.
RESULTS: All 16 MS patients investigated and none of the HCs met the VH criteria for CCSVI (P<0.0001). MS patients showed significantly lower net CSF flow compared to the HC (P=0.038) that was associated with number of anomalous VH criteria present (r=0.79, P<0.001). Moreover, increases in the number of anomalous VH criteria present were negatively associated with lower whole brain volume (Spearman R=-0.5, P=0.05).
CONCLUSION: VH changes occur more frequently in MS patients than controls. Altered VH is associated with abnormal CSF flow dynamics and decreased brain volume.

Entities:  

Mesh:

Year:  2010        PMID: 20351670

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  7 in total

1.  Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

Authors:  M Filippi; M A Rocca; F Barkhof; R Bakshi; F Fazekas; O Khan; D Pelletier; A Rovira; J Simon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

2.  Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound: recommendations for a protocol.

Authors:  A N Nicolaides; S Morovic; E Menegatti; G Viselner; P Zamboni
Journal:  Funct Neurol       Date:  2011 Oct-Dec

Review 3.  Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis.

Authors:  A Ghezzi; G Comi; A Federico
Journal:  Neurol Sci       Date:  2010-12-15       Impact factor: 3.307

4.  Intracranial pressure in the American Alligator (Alligator mississippiensis): reptilian meninges and orthostatic gradients.

Authors:  Tatyana Kondrashova; Joshua Blanchard; Lucas Knoche; James Potter; Bruce A Young
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2019-12-06       Impact factor: 1.836

5.  No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.

Authors:  R Zivadinov; G Cutter; K Marr; M Ramanathan; R H B Benedict; N Bergsland; C Morgan; E Carl; D Hojnacki; E A Yeh; L Willis; M Cherneva; C Kennedy; M G Dwyer; B Weinstock-Guttman
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

6.  Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis: The Role of Phase-Contrast MRI in the Differential Diagnosis of Active and Chronic Disease.

Authors:  Serkan Öner; Ayşegül Sağır Kahraman; Cemal Özcan; Zeynep Maraş Özdemir; Serkan Ünlü; Özden Kamışlı; Zülal Öner
Journal:  Korean J Radiol       Date:  2018-01-02       Impact factor: 3.500

7.  Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.

Authors:  Massimiliano Farina; Eugenio Novelli; Raffaello Pagani
Journal:  BMC Neurol       Date:  2013-11-05       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.